Many immunocompromised Americans, including people with cancer, autoimmune disorders and transplanted organs, are impatiently awaiting what could be their ticket back to some semblance of normalcy: the ability to receive periodic injections of long-acting monoclonal antibodies. This, research suggests, could provide them the substantial protection against Covid-19 that in their cases vaccination may not.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/53XNUANG5ZIGPL5FDTP4AO37EQ.jpg)
